E-ISSN 2063-5346
 

Original Article 


HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL

J.Praveen kumar, Dr.P.Geetha.

Abstract
Diverse NP formulations were allotted in drug development in an try to growth performance, protection and
tolerability of integrated tablets. The destiny look at entails delivering drug/bioactive based totally on a unmarried
nanoplatform poly lactic-co- glycolic acid (PLGA) for superior efficacy, synergistic effect, and reduced toxicity.. In this
context, NP formulations that increase solubility, control release, and/or affect the in vivo disposition of drugs, had been
evolved to enhance the pharmacokinetic and pharmacodynamic homes of encapsulated drugs. The goal of this effort is to put
together and compare Poly (D, L-Lactide-co-glycolide) (PLGA) Nanoparticles (NPs) of Castalin, an anticancer agent loaded
by solvent displacement method by stabilizer (poly vinyl alcohol). The nanoparticles have been formulated further to then
characterized for percent yield, encapsulation performance, surface morphology, particle dimension, drug distribution
studies, drug polymer interaction research and in vitro drug launch profiles. The set NPs were characterized by FT-IR, DSC,
drug loading, entrapment efficiency, particle size, and surface morphology by Atomic force microscopy (AFM), X-ray
diffraction and in-vitro studies. FT-IR and DSC research indicated that there was no interplay between the drug and polymer.
The morphological studies executed by using AFM showed uniform and spherical fashioned discrete particles without
aggregation and easy in surface morphology with a nano length varies of 144 nm. The enormous quantity of news on PLGA
NPs used as drug delivery systems during cancer management effects to see the potential of PLGA NPs used as drug
delivery systems in the course of most cancer therapeutics and encourages similarly translational research.

Key words: Nanoparticles; PLGA; Castalin; most cancers; goal transport sustained release.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by J.Praveen kumar
Articles by Dr.P.Geetha
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

J.Praveen kumar, Dr.P.Geetha. HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL. ECB. 2022; 11(6): 82-89. doi:10.31838/ecb/2022.11.06.012


Web Style

J.Praveen kumar, Dr.P.Geetha. HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL. https://www.eurchembull.com/?mno=112616 [Access: November 29, 2022]. doi:10.31838/ecb/2022.11.06.012


AMA (American Medical Association) Style

J.Praveen kumar, Dr.P.Geetha. HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL. ECB. 2022; 11(6): 82-89. doi:10.31838/ecb/2022.11.06.012



Vancouver/ICMJE Style

J.Praveen kumar, Dr.P.Geetha. HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL. ECB. (2022), [cited November 29, 2022]; 11(6): 82-89. doi:10.31838/ecb/2022.11.06.012



Harvard Style

J.Praveen kumar, Dr.P.Geetha (2022) HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL. ECB, 11 (6), 82-89. doi:10.31838/ecb/2022.11.06.012



Turabian Style

J.Praveen kumar, Dr.P.Geetha. 2022. HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL. European Chemical Bulletin, 11 (6), 82-89. doi:10.31838/ecb/2022.11.06.012



Chicago Style

J.Praveen kumar, Dr.P.Geetha. "HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL." European Chemical Bulletin 11 (2022), 82-89. doi:10.31838/ecb/2022.11.06.012



MLA (The Modern Language Association) Style

J.Praveen kumar, Dr.P.Geetha. "HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL." European Chemical Bulletin 11.6 (2022), 82-89. Print. doi:10.31838/ecb/2022.11.06.012



APA (American Psychological Association) Style

J.Praveen kumar, Dr.P.Geetha (2022) HERBAL STUDY OF FORMULATION BASED ON CASTALIN FOR ANTICANCER POTENTIAL. European Chemical Bulletin, 11 (6), 82-89. doi:10.31838/ecb/2022.11.06.012